EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Current features

AI in Clinical Trial Recruitment: Proceed with Cautious Optimism

Artificial Intelligence (AI) is rapidly reshaping the landscape of clinical research, offering transformative solutions to longstanding challenges in trial design, e...
Continue Reading →
Current features

Clinical Trials: A Logistical Nightmare?

For clinical trial managers, the list of planning variables can seem endless. Cohort selection and patient recruitment, regulatory engagement and compliance, data ma...
Continue Reading →
Current features

Beyond Manufacturing: Strategic Clinical Supply Management for Global Trial Success

Clinical trials are the critical stages in which scientific innovation is tested and validated in patients, collecting data that will transform experimental therapie...
Continue Reading →
Current features

Harnessing Transformative Data Visualisation for Clinical Research: From Insights to Action

In the complicated realm of clinical research, data abounds – yet, in its raw form, this data remains scattered, isolated and often difficult to use. The true power ...
Continue Reading →
Current features

Reimagining Clinical Trial Management: AI as the Virtual Team Member

Currently, clinical trials face challenges such as complex protocols, extended timelines, substantial costs and increasing regulatory requirements. As these trials b...
Continue Reading →
Current features

Redefining Site Relationships in Clinical Trials

Redefining Site Relationships in Clinical Trials Insights from WCG 2025 CenterWatch Global Site Relationship Survey At the heart of every clinical trial lies a co...
Continue Reading →
Current features

Beyond Enrolment: How Community-Based Oncology Practices Drive Patient Retention in Early-Phase Trials

Recruitment remains a well-known hurdle in Phase 1 oncology clinical trials, but what happens after enrolment is equally vital: patient retention. Keeping patients o...
Continue Reading →
Current features

Supercharging Rare Disease Drug Development Through Human Connection

Drug development commonly encounters a bottleneck at the clinical trial stage. Patient recruitment is notoriously challenging, with many studies facing costly delays...
Continue Reading →
Current features

Harmonising Global Approaches to Transformative Theranostics

Cancer prevalence is rising globally. Radiopharmaceuticals and Theranostics offer precise, targeted diagnostic and therapeutic solutions for safer, more tolerable on...
Continue Reading →
Current features

Challenges in the Post-marketing Investigations for Medical Devices

As the European and overall worldwide regulation strives to become clearer, unambiguous, harmonised and as a result, more restrictive and demanding, this tendency st...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18